Tag Archives: US FDA SAYS BENEFITS OUTWEIGH RISKS FOR PFIZER VACCINE IN CHILDREN

Scientists at the US Food and Drug Administration (FDA) said on Friday that the likely benefits of giving the Pfizer COVID-19 vaccine to 5 to 11 year olds clearly outweigh the risks of rare cases of heart inflammation. Earlier on Friday, the vaccine makers said their shot showed 90.7% efficacy against the coronavirus in a clinical trial of children 5 …

Read More »